At a time when the gaming ecosystem in India is facing a funding downturn due to doubts around taxation, global VC fund ...

Q1 2025 Earnings Call Transcript June 12, 2025 Operator: Good day, and welcome to the First Quarter 2025 Year-end Digital ...

Operator: Good morning and good evening, ladies and gentlemen. Thank you for standing by, and welcome to QuantaSing ...

Q1 2026 Earnings Call Transcript June 3, 2025 Asana, Inc. beats earnings expectations. Reported EPS is $0.05, expectations were $0.02. Operator: Good afternoon, and thank you for joining us on today’s ...

It is expected to contribute to growing bp’s global upstream production to 2.3-2.5mmboed by 2030, with capacity to increase further to 2035. bp and partners have approved the next phase of development ...

TTFields therapy concomitant with gemcitabine and nab-paclitaxel is the first treatment to show a clinically meaningful and statistically significant improvement in overall survival (OS) for ...

Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis ...

In the Phase 3 AFFIRM-AL clinical trial ... and a potential workforce reduction; and our evaluation of business options. These statements are based on estimates, projections and assumptions ...

"I'm telling myself, like, I can make it through the last phase. I did it all three years. So this is it, right?" she said. "Like I've got seven months to go." IDOT also said there will be ramp ...

Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study Biomarkers could be utilized to predict and provide better patient outcomes ...